On July 25, 2019 Boston Scientific Corporation (NYSE: BSX) reported that it will participate in the 39th Annual Canaccord Genuity Growth Conference on Thursday, August 8, 2019 in Boston (Press release, Boston Scientific, JUL 25, 2019, View Source [SID1234537770]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Susie Lisa, vice president, Investor Relations, and Lauren Tengler, director, Investor Relations, will participate in a 25-minute question-and-answer session with the host analyst beginning at approximately 10:00 a.m. EDT. A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.
A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.